US Patent Issued to SCYNEXIS on April 7 for "Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia" (New Jersey, Florida Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,266, issued on April 7, was assigned to SCYNEXIS INC. (Jersey City, N.J.). "Triterpenoid antifungals for the treatment or prevention of Pne... Read More

US Patent Issued to Gilead Sciences on April 7 for "Capsid inhibitors for the treatment of HIV" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,267, issued on April 7, was assigned to Gilead Sciences Inc. (Foster City, Calif.). "Capsid inhibitors for the treatment of HIV" was invent... Read More

US Patent Issued to Amicus Therapeutics on April 7 for "Methods of treating Fabry disease in patients having a mutation in the GLA gene" (New Jersey Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,268, issued on April 7, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Methods of treating Fabry disease in patients having a mu... Read More

US Patent Issued to Takeda Pharmaceutical on April 7 for "Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,269, issued on April 7, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Method for enhancing the pharmacokinetics or increa... Read More

US Patent Issued to Cambridge Cognition on April 7 for "Schizophrenic disorder treatment using combination therapy" (British Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,270, issued on April 7, was assigned to Cambridge Cognition Ltd. (Cambridge, Great Britain). "Schizophrenic disorder treatment using combin... Read More

US Patent Issued to Health Research on April 7 for "Combination therapy for cancer" (New York Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,271, issued on April 7, was assigned to Health Research Inc. (Buffalo, N.Y.). "Combination therapy for cancer" was invented by Scott I. Abr... Read More

US Patent Issued to Ceruvia Lifesciences on April 7 for "2-bromo-lysergic acid diethylamide for substance abuse" (Connecticut Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,272, issued on April 7, was assigned to Ceruvia Lifesciences LLC (Greenwich, Conn.). "2-bromo-lysergic acid diethylamide for substance abus... Read More

US Patent Issued to Satsuma Pharmaceuticals on April 7 for "Intranasal DHE for the treatment of headache" (Japanese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,273, issued on April 7, was assigned to Satsuma Pharmaceuticals Inc.. "Intranasal DHE for the treatment of headache" was invented by Shunji... Read More

US Patent Issued to Gulch Pharma on April 7 for "Method for preparing a crystalline form of rabeximod" (Swedish Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,274, issued on April 7, was assigned to Gulch Pharma AB (Sollentuna, Sweden). "Method for preparing a crystalline form of rabeximod" was in... Read More

US Patent Issued to The Regents of the University of California on April 7 for "Immunophilin binding agents and uses thereof" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,275, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Immunophilin binding agents and use... Read More

• ««
• «
• 1232
• 1233
• 1234
• 1235
• 1236
• 1237
• 1238
• 1239
• 1240
• 1241
• »
• »»